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The author first found some green fluorescent substances in the concentrated synovial 
fluid by means of CRAMMERS and ascertained that a part of these was derived from 
tryptophan intermediates by paper chromatography. 
In the present study, the author attempted to determine the tryptophan in blood and 
synovial fluid, and also the tryptophan intemediates in synovial fluid in order to clasify 
the specifity of tryptophan metabolism in rheumatoid arthritis as an inflammatory disease 
and in osteoarthritis as a noninflammatory disease, respectively. 
Concentrated synovial fluid was developed by means of descending paper chromato・ 
graphy. The fluorescent spots were noted under an ultraviolet light and the Rf values 
of the spots were determined. Spots of anthranilic acid, xanthurenic acid and 3-hydro・ 
xykynurenine derivate were found in both diseases, but d-kynurenine and 1 kynurenine 
were found in rheumatoid arthritis only. 
The tryptophan content was determined by using ultraviolet absorption spectra and 
was calculated by coefficient of molecular absorption of GOODWIN. The tryptophan content 
in the synovial fluid in rheumatoid arthritis was found to be increased as compared with 
that of osteoarthritis, but no change was found in the blood in rheumatoid arthritis, osteo・
arthritis and healthy subjects. 0io relation was found between the tryptophan contents in 
blood and the existence of joint hydrops in both diseases, and also between the trypto・
phan content in blood and synovial fluid and the stage in rheumatoid arthritis. On the 
other hand, there is a close relation between the tryptophan content in synovial fluid and 
the increased blood sedimentation rate in rheumatoid arthritis. These findings play an 
important role for the diagnosis of definite rheumatoid arthritis. 
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On the tryptophan intermediates in synovial fluid, the kynurenine content in rheuma-
toid arthritis was eight times more than that of osteoarthritis, and the anthranilic acid 
content in rheumatoid arthritis increased four times in comparison with that of osteoar-
thritis, while kynurenic acid and nicotinic acid contents in rheumatoid arthritis were about 
half of that of osteoathritis, but no change was found xanthurenic acid in both dis田S白・
It app田rsthat increased tryptophan and kynurenine in synovial fluid is due to the 
fal of tryptophan pathway by the decrease of enzymatic activity in synovial fluid in rheuma-
toid arthritis. It is suggested that there are different metabolic pathways between synovial 
fluid and blood, and that some factors, whether latent or manifest dysfunctions of liver 





Tryptophan (Try）は Hopkinsおよび Cole(1901) . よび関節液中のTry，さらに関節液中におけるTry中



































































（血液又は関節波I1 mlをとり，それを O.lN-NaOH 
で正確にlOOmlとし，血液の場合はさらにその 1ml 
をO.lN-NaOH で10倍に稀釈し，その』 mlを試料と
して， 目立製分光々度計により， 280. 0 mμ および
294. 4 mμ の吸光度を測定し， Goodwinの分子吸光係
数を乗じ既定の方法で算出した．
第3項 Kynおよび Anthranilicacidの定量
Kynと A11tl11;inilicacid I .-¥A Iの分雛は Brownお
よび Price25＞の方法により，定量は Walsh26＞の方法
にしたがった．ただし前処置として関節液は蛋白質を
多量に含有するため Ethanol•Acetone ( 1 1 I溶液を
試料の約10｛音量加えて， よく撹持した． それを浦過
後一定量lζ濃縮し， あらかじめ活性化されたカラム
(D＂川~ :i01 Hづ， lx7cm〕lζ吸着させた． ζれを0.1 
N-HCI 80ml. 0. 5N-HCI lOOml, 1. ON-HCI lOOml. 
2. 0:'-1-HCI lOOml, 4. ON-HCI lOOmlで抽出し．それ
ぞれを fracl'ion主，B,C,D,Eとした．
fraction E lζは Kynが含有されており． 乙れを一






第4項 Kynurenicacidおよび Xan¥hurenicacid 
の定量
Kynurenic acid (KA）および Xanthurenicacid I XA I 




たカラム （Dowex50(H+), 1x7 cm）に吸着させた．
それを0.2:¥-HCI 50ml, 0. :'iN HCl lOOml，蒸留水20
mlのj蜘と洗い， 396mlの蒸留水で抽出し，それに0.5
M-phosphate buffer （凶7.-1! 4 ml を加え総量400ml
としfこ．
XAはその400mlより 5mlをとり0.005M-phosphate 
buffer (pH7. 4) 1 mlを加え，さらに cone.HzS04」
mlを加えて， Aminco-Bowman分光鐙光光度計ICよ
り， Fluor田cence435 mμ, Activating 340 mμ で測定し
た．
XAは 400mlより 5mlをとり 0.005 M-ph曲phate
buffer (pH7. 4) 1 ml，さらに飽和 NaOH』mlを加え
た後， Aminco-Bowman分光後光光度計により Fluo-
rescence 530 mμ, Activating 370 mμ で測定した．
第5項 Nicotinic acidの定量
















ウマチ患者の関節液では Rf値， 0. 18, 0. 35, 0. 40, 
0. :i. 0. 960のところに鐙光物質を認め，また変形性














Table 1 Color Reaction of Chromatogram of the Synovial Fluid in the Patient 
with Rheumatoid Arthritis and Osteoarthritis 
fluoresce口氏 gr田n｜凶uis
: o. 086 J o. 18 ! o. 35 
－~nhydrin －一〕－ 1 + ~t=~ ~ -+_ 
Ehrlich aldeh凶： + ' + I + + + I 
I i Glucuronide I ,. I I I I i I D- I L- I Xanthurenic I 









Osteo orthriti s 
Fig. 1 Fluorescent Substance in the Synovial Fluid 
in the Patient with Rheumatoid Arthritis and 
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Fig. 2 Relationship between Tryptophan Content 
in the Synovial Fluid and Blood Sぞdimentation










Tryptophan Content in the Blood and Synovial Fluid in the Patient with Rheumatoid Arthritis 
1制 1中！’‘ t
1 I S.T. I♀i 59 
2 1 K. H. I：♀ I:; Ii 
3 I H. T.1♀ I s7 ) 
・l S. T. i ♀ I 60 
5 ! N. H. ！♀I 55 
6 IR. 0. I合 I32 
7 I K. K.：合 I73 
8 I K. 0. l♀I 4 I 
9 I U. H. i ♀ I 67 ; 
10 I s.K. i♀ I 54 I 
11 'M. S. I♀ I 20 1 
12 I H. H. I♀ I 76 i 
13 I S. T. i合 I55 : 
14 i R. K. I♀ I 581 
15 j H. S. ！合；13I 
16 M. Y. I♀ I :!9
17 . Z. T.：♀I 33 l 
18 'M. T. I♀ I 37I 
19 I S. M. I♀ j 18' 
20 ! Y. K. I合 I45 I 
21 , G. K. ！合I70 j 
22 I s.H. I♀ I 47
23 i R. T. l♀ I 31I 
24 I. S. I♀ I 54 ! 
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243. 9 mM/ml 
287.3 
synovial fluid 
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Table 4 Relationship between Tryptophan 
Content in the Blood and Joint Hydrops 
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Table 5 Relationship between Tryptophan Content 
in the Synovial Fluid and Blood, and Stage in the 
Patiant with Rheumatoid Arthritis 
blood 
1-1. 80 mM/ml :!71. 9 mM/ml 
足当当l 当りU.υ
20. 72 I 251. 7 
20. 72 I 285. 3 
2-1. 56 I 250. 3 
Mean ! 20. 82 I 271. 8 
22. 9!i I 198. s 
22. 94 I 302. 1 
17. 78 I 323. 7 
22.-1』 I22-1. -1 
22. 01 i :!8り2
11. 1-1 ; '.!ii. -I 
23. s2 I 290. o 
:!Ii I. 1 
1コh:i.-I 
I :nci.-1 
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Fig. 3 Relationship 険tweenTryptophan Content 
in the Synovial Fluid and Blood Sedimentョtion 
Rate in the Patient with Rheumatoid Arthritis 
and Osteoarthritis. 
synovial fluid 











1. 61 μg/ml，変形相関節症が平均9.54士2.99 μg/mlで
あり，逆iζ変形性関fYrlii＇φが関節リウ 7チの約2倍のi習



















Table 6 Kynurenine and Anthranilic Acid Content in the Synovial Fluid in the Patient 
with Rheumatoid Arthritis and Osteoarthritis 
anth. acid 




























































Table 7 Kynurenic Acid and Xanthurenic Acid Content in the Synovial Fluid in the Patient 
with Rheumatoid Arthritis and Osteoarthritis 
xan. acid 
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・5・ K. K. I 
玉 Y.0. 
』2 Y. T. I 
6 H. S. 
Mean 
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Table 8 Nicotinic Acid Content in the Synovial Fluid in the Patient 
with Rheumatoid Arthritis and Osteoarthritis 
Patient 
ぽ X 云司 日Oc司sedim. rate 
己乞』戸一亡イ‘
G. Y. 0 32 52, 80 
H. T. ♀ 58 37, 6• 
T. S. 66 33, 70 
G. K. ｜会 70 95, 122 
可 K ｜♀ 20 38, 67 
Mean 
M. T. 3, 8 
Y. T. 早川 29. 55 
K. S. ♀ 88 5 17 
Y. 0. ♀ '14 l, 6 
































Table 2, 3, Fig. 2が示すように，血液中 Try含量
は両疾患および対照例を含めて有意差を認めなかっ
f AS叫 RA I CRP--; 
+ I +2 a.耐 g/ml
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関節液の Try中間代謝産物については， Table6～ 
8, Fig目 4が示すように， Kyn値は関節リウマチが平
均62.79土 42.14 μg/ml, 変形性関節症は平均8.74士
6. 44μg/mlであり，関節リウマチが変形性関節症に比
較して約8倍の高l1'iをl沼めだ．またAλ値は関節リウ





















作用を受け Kynとなる． さらに Kynからは三つの
pathway l乙分れ，一つは Pyridoxal-5-phosphate(P主LP1
を補酵素とする Kynureninaseの作用を受けAAt乙至る
pathway, P ALPを補酵素とする Supernatantkynure-
nine aminotransferaseの作用を受けてKAtC至る path-
wayと Kynurenine3-hydroxylaseの作用を受けて 3-

















！宮均nurenln・P争I Anlll.Acld蜘 l 帆 Acid "%1 x・n.Acid 11~ ， Nie.Acid 
ιi I Ot 2 I 2 
so l 
RA OA RA OA RA OA RA OA RA OA 
Fig. 4 Kynurenine, Anthranilic acid, Kynurenic acid, Xanthurenic acid and Nicotinic 






K>:nurenlnase • l Kynurenin・e aminotransferase 
/Anthranllic acid巾竺竺竺竺恒型型唖・...・M・...・H・• /Kynu問nicacid I 
t'yp I : Pyp 
Ky間 rllne
3-hydroxylose l : Miio伽 ndrial
: Kynurenlne aminotransferase 
3-Hydroxy1<yn~enlne ＿＿＿＿＿＿一一一一IXa酬帥nlcacid/ 
Pyp I i Kynureninase Pyp 
3叫 droxy<1nlhran骨IC日MI i Pyp = p山口1-5-ph叩 e
I Nlcotlnlc acid I ーーー ーー－ Rheumatoid arthritis 
------- Osteoarthritis 
Fig. 5 Compari回nof Metabolic Pathway of Tryptophan in the Synovial Fluid in 
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Fig. 3 Relationship Letwe~n Trq)topl1:i円 Content
in the %、noYialFluid and Blood Sedunentation 
Rate in the Patient with Rheumatoid Arthritis 
and Osteoarthritis. 
30 50 100 
Blood s・dimen1alion R。le
Fig. 2 Tryptophan Content in the S、日川i.dFluid 
and the Blood in the patient with Rheumatoid 
Arthritis and Osteoarthritis. 
